6533b856fe1ef96bd12b1d99

RESEARCH PRODUCT

Editorial: IDASPHERE phase I trial for chemoembolisation for HCC - authors' reply: a necessary step for treatment optimisation and standardisation

Laurent BedenneMathieu BoulinBoris Guiu

subject

Malemedicine.medical_specialtyCarcinoma HepatocellularHepatologybusiness.industryLiver NeoplasmsGastroenterologyPhase (combat)medicineHumansFemalePharmacology (medical)Medical physicsChemoembolization TherapeuticIdarubicinbusinesshttps://doi.org/10.1111/apt.12835